Copyright Reports & Markets. All rights reserved.

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview

      • 1.1 Product Overview and Scope of PARP (Poly ADP-Ribose Polymerase) Inhibitor
      • 1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Type
        • 1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Lynparza
        • 1.2.3 Diraparib
        • 1.2.4 Rucaparib
        • 1.2.5 Talazoparib
        • 1.2.6 Others
      • 1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Application
        • 1.3.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Pharmacial
        • 1.3.4 Retail
        • 1.3.5 Online
      • 1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Region
        • 1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size
        • 1.5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2014-2025)
        • 1.5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production (2014-2025)

      2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competition by Manufacturers

      • 2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites, Area Served, Product Types
      • 2.5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competitive Situation and Trends
        • 2.5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Concentration Rate
        • 2.5.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Regions

      • 3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Regions
      • 3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions (2014-2019)
      • 3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production
        • 3.4.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019)
        • 3.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production
        • 3.5.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019)
        • 3.5.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Production (2014-2019)
        • 3.6.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019)
        • 3.6.2 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Production (2014-2019)
        • 3.7.1 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019)
        • 3.7.2 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions

      • 4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions
      • 4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019)
      • 4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019)
      • 4.4 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019)
      • 4.5 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019)

      5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price Trend by Type

      • 5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Type (2014-2019)
      • 5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Type (2014-2019)
      • 5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Type (2014-2019)
      • 5.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth by Type (2014-2019)

      6 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Analysis by Applications

      • 6.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Share by Application (2014-2019)
      • 6.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business

      • 7.1 Tesaro
        • 7.1.1 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites and Area Served
        • 7.1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Introduction, Application and Specification
        • 7.1.3 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Clovis Oncology
        • 7.2.1 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites and Area Served
        • 7.2.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Introduction, Application and Specification
        • 7.2.3 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AstraZeneca
        • 7.3.1 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites and Area Served
        • 7.3.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Introduction, Application and Specification
        • 7.3.3 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Abbvie
        • 7.4.1 Abbvie PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites and Area Served
        • 7.4.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Introduction, Application and Specification
        • 7.4.3 Abbvie PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served

      8 PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Cost Analysis

      • 8.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor
      • 8.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List
      • 9.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast

      • 11.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast
        • 11.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price and Trend Forecast (2019-2025)
      • 11.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Forecast by Regions (2019-2025)
        • 11.2.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025)
        • 11.2.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025)
      • 11.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025)
        • 11.3.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025)
        • 11.3.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025)
        • 11.3.4 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025)
      • 11.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, including exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors block an enzyme critical to the repair of single stranded breaks in DNA. Inhibition of this DNA repair enzyme can lead to cell death, particularly in cancer cells that carry deficiency in other DNA repair pathways.
        The U.S. is the major market of PARP inhibitor supported by PARPi for ovarian cancer in the market. The U.S. region is likely to experience further growth of PARP inhibitor market with upcoming PARP inhibitors and growing cases of cancer.

        The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on PARP (Poly ADP-Ribose Polymerase) Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall PARP (Poly ADP-Ribose Polymerase) Inhibitor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Tesaro
        Clovis Oncology
        AstraZeneca
        Abbvie
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Lynparza
        Diraparib
        Rucaparib
        Talazoparib
        Others

        Segment by Application
        Hospitals
        Pharmacial
        Retail
        Online

        Buy now